Page last updated: 2024-11-02

phenobarbital and Arachnoidal Cerebellar Sarcoma, Circumscribed

phenobarbital has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruggiero, A1
Buonuomo, PS1
Maurizi, P1
Cefalo, MG1
Cefalo, MP1
Corsello, M1
Riccardi, R1

Other Studies

1 other study available for phenobarbital and Arachnoidal Cerebellar Sarcoma, Circumscribed

ArticleYear
Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy.
    Journal of neuro-oncology, 2007, Volume: 85, Issue:2

    Topics: Anticonvulsants; Brain Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Female; Hum

2007